K. Lehtiö

发表

A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study

J. Kononen, M. Chua, J. Keyriläinen, 2020, Diagnostics.

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.

Tove Grönroos, Heikki Minn, Vesa Oikonen, 2004, International Journal of Radiation Oncology, Biology, Physics.

Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET

H. Minn, K. Lehtiö, T. Grönroos, 2001 .

Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy

H. Sipilä, H. Minn, G. Komar, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

1 In Vivo Imaging of Prostate Cancer Using [ 68 Ga ]-Labeled Bombesin Analog BAY 86-7548

I. Jambor, H. Minn, R. Schibli, 2013 .

Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET

P. Kronqvist, H. Minn, R. Grenman, 2014, BMC Cancer.

Pharmacokinetics of [18F]FETNIM: a potential marker for PET.

H. Minn, K. Lehtiö, T. Grönroos, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment

T. Vahlberg, A. Mäkitie, K. Vuolukka, 2022, European Archives of Oto-Rhino-Laryngology.

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.

V. Kataja, A. Jukkola-Vuorinen, H. Joensuu, 2009, The Lancet. Oncology.

Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET

V. Oikonen, J. Jääskeläinen, H. Minn, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Imaging of tumor hypoxia to predict treatment sensitivity.

H. Minn, G. Komar, K. Lehtiö, 2008, Current pharmaceutical design.

In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548

I. Jambor, H. Minn, R. Schibli, 2013, Clinical Cancer Research.

Plasma Pharmacokinetics, Whole-Body Distribution, Metabolism, and Radiation Dosimetry of 68Ga Bombesin Antagonist BAY 86-7548 in Healthy Men

I. Jambor, H. Minn, A. Rottmann, 2013, The Journal of Nuclear Medicine.

Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET

H. Minn, T. Viljanen, K. Lehtiö, 2014, BMC Cancer.

Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio

Tove Grönroos, Heikki Minn, Vesa Oikonen, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.

V. Oikonen, H. Minn, P. Nuutila, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In response to Wang et al

H. Minn, K. Lehtiö, R. Grénman, 2005 .

18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.

V. Oikonen, H. Minn, K. Lehtiö, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment

T. Vahlberg, A. Mäkitie, K. Vuolukka, 2022, European Archives of Oto-Rhino-Laryngology.

In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548

I. Jambor, H. Minn, R. Schibli, 2013, Clinical Cancer Research.